| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| C4 Therapeutics, Inc. | Chief Business Officer | Common Stock | 52.3K | $342K | $6.53 | Feb 14, 2024 | Direct |
| C4 Therapeutics, Inc. | Chief Business Officer | Stock Option (Right to Buy) | 115K | Mar 7, 2024 | Direct | ||
| C4 Therapeutics, Inc. | Chief Business Officer | Performance Restricted Stock Units | 16.5K | Aug 30, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CCCC | C4 Therapeutics, Inc. | Mar 7, 2024 | 2 | $0 | 4 | Mar 8, 2024 | Chief Business Officer |
| CCCC | C4 Therapeutics, Inc. | Feb 13, 2024 | 3 | -$11.3K | 4 | Feb 15, 2024 | Chief Business Officer |
| CCCC | C4 Therapeutics, Inc. | Sep 18, 2023 | 1 | $0 | 4 | Sep 19, 2023 | Chief Business Officer |
| CCCC | C4 Therapeutics, Inc. | Aug 30, 2023 | 3 | -$1.94K | 4 | Aug 31, 2023 | Chief Business Officer |
| CCCC | C4 Therapeutics, Inc. | Feb 13, 2023 | 2 | $0 | 4 | Feb 15, 2023 | Chief Business Officer |
| CCCC | C4 Therapeutics, Inc. | Jan 30, 2023 | 3 | -$9.51K | 4 | Feb 1, 2023 | Chief Business Officer |
| CCCC | C4 Therapeutics, Inc. | May 26, 2022 | 1 | -$7.73K | 4/A | Jun 14, 2022 | Chief Business Officer |
| CCCC | C4 Therapeutics, Inc. | May 25, 2022 | 2 | $0 | 4 | May 27, 2022 | Chief Business Officer |
| CCCC | C4 Therapeutics, Inc. | Mar 16, 2022 | 0 | $0 | 3 | Mar 17, 2022 | Chief Business Officer |